Esperion Therapeutics (ESPR)
(Real Time Quote from BATS)
$1.70 USD
-0.01 (-0.59%)
Updated Aug 28, 2024 01:08 PM ET
3-Hold of 5 3
C Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.16 |
EPS Last Quarter | -0.05 |
Last EPS Surprise | 66.67% |
ABR | 1.86 |
Earnings ESP
|
8.65% |
---|---|
Current Year | -0.04 |
Next Year | 0.39 |
EPS (TTM) | -0.58 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 55.87M | 96.69M | 354.99M | 506.67M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 65.87M | 184.76M | 462.20M | 664.80M |
Low Estimate | 48.85M | 55.31M | 298.26M | 402.15M |
Year ago Sales | 33.97M | 32.25M | 116.33M | 354.99M |
Year over Year Growth Est. | 64.45% | 199.80% | 205.14% | 42.73% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.16 | -0.02 | -0.04 | 0.39 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | -0.11 | 0.38 | 0.31 | 1.29 |
High Estimate | -0.10 | 0.38 | 0.31 | 1.29 |
Low Estimate | -0.21 | -0.19 | -0.16 | 0.10 |
Year ago EPS | -0.37 | -0.50 | -2.03 | -0.04 |
Year over Year Growth Est. | 56.76% | 96.00% | 98.03% | 1,080.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 2 | 3 |
Up Last 60 Days | 1 | 2 | 3 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 2 | 1 |
Down Last 60 Days | 3 | 2 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.16 | -0.02 | -0.04 | 0.39 |
7 Days Ago | -0.16 | -0.02 | -0.04 | 0.39 |
30 Days Ago | -0.14 | -0.10 | 0.03 | 0.32 |
60 Days Ago | -0.11 | -0.09 | 0.03 | 0.31 |
90 Days Ago | -0.11 | -0.09 | -0.05 | 0.32 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.14 | 0.04 | -0.02 | 0.46 |
Zacks Consensus Estimate | -0.16 | -0.02 | -0.04 | 0.39 |
Earnings ESP | 8.65% | 283.34% | 58.33% | 16.67% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.05 | 0.34 | -0.50 | -0.37 | NA |
Estimate | -0.15 | -0.08 | -0.53 | -0.42 | NA |
Difference | 0.10 | 0.42 | 0.03 | 0.05 | 0.15 |
Surprise | 66.67% | 525.00% | 5.66% | 11.90% | 152.31% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more